These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18592373)

  • 21. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines.
    Lai L; Yuan L; Cheng Q; Dong C; Mao L; Hill SM
    Breast Cancer Res Treat; 2009 Nov; 118(2):293-305. PubMed ID: 18979234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D
    Lundqvist J; Kirkegaard T; Laenkholm AV; Duun-Henriksen AK; Bak M; Feldman D; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2018 Mar; 177():171-178. PubMed ID: 28610873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.
    Cos S; González A; Güezmes A; Mediavilla MD; Martínez-Campa C; Alonso-González C; Sánchez-Barceló EJ
    Int J Cancer; 2006 Jan; 118(2):274-8. PubMed ID: 16080194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis.
    Alonso-González C; González A; Martínez-Campa C; Menéndez-Menéndez J; Gómez-Arozamena J; García-Vidal A; Cos S
    Cancer Lett; 2016 Jan; 370(1):145-52. PubMed ID: 26497762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melatonin, environmental light, and breast cancer.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Esquifino AI; Cardinali DP; Maestroni GJ
    Breast Cancer Res Treat; 2008 Apr; 108(3):339-50. PubMed ID: 17541739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melatonin, an inhibitory agent in breast cancer.
    Nooshinfar E; Safaroghli-Azar A; Bashash D; Akbari ME
    Breast Cancer; 2017 Jan; 24(1):42-51. PubMed ID: 27017208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic modification in 4T1 mouse breast cancer model by artificial light at night and melatonin - the role of DNA-methyltransferase.
    Agbaria S; Haim A; Fares F; Zubidat AE
    Chronobiol Int; 2019 May; 36(5):629-643. PubMed ID: 30746962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
    Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin as an Oncostatic Molecule Based on Its Anti-Aromatase Role in Breast Cancer.
    Jin Y; Choi YJ; Heo K; Park SJ
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33406787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects.
    Cini G; Neri B; Pacini A; Cesati V; Sassoli C; Quattrone S; D'Apolito M; Fazio A; Scapagnini G; Provenzani A; Quattrone A
    J Pineal Res; 2005 Aug; 39(1):12-20. PubMed ID: 15978052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
    Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
    Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of melatonin's inhibitory actions on breast cancers.
    Proietti S; Cucina A; Reiter RJ; Bizzarri M
    Cell Mol Life Sci; 2013 Jun; 70(12):2139-57. PubMed ID: 23007844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aromatase and breast cancer susceptibility.
    Probst-Hensch NM; Ingles SA; Diep AT; Haile RW; Stanczyk FZ; Kolonel LN; Henderson BE
    Endocr Relat Cancer; 1999 Jun; 6(2):165-73. PubMed ID: 10731105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of aromatase by nuclear receptors.
    Yanase T; Mu YM; Nishi Y; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):187-92. PubMed ID: 11850224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aromatase inhibitor-induced joint pain: melatonin's role.
    Burk R
    Med Hypotheses; 2008 Dec; 71(6):862-7. PubMed ID: 18782656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production.
    Alvarez-García V; González A; Alonso-González C; Martínez-Campa C; Cos S
    J Pineal Res; 2012 Apr; 52(3):282-90. PubMed ID: 22151118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells.
    González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ; Cos S
    Br J Cancer; 2007 Sep; 97(6):755-60. PubMed ID: 17700567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
    Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
    J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells.
    Mahalingaiah PK; Ponnusamy L; Singh KP
    Breast Cancer Res Treat; 2015 Aug; 153(1):41-56. PubMed ID: 26208486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian disruption and breast cancer: from melatonin to clock genes.
    Stevens RG
    Epidemiology; 2005 Mar; 16(2):254-8. PubMed ID: 15703542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.